WATCH TV LIVE

Skip to main content
NEWSMAX TV HEALTH MONEY WORLD
Tags: merck covid treatment molnupiravir | china

Merck's COVID Treatment to Launch in China Friday

Merck's COVID Treatment to Launch in China Friday
(AP)

Wednesday, 11 January 2023 07:44 AM EST

Merck & Co.'s COVID-19 antiviral treatment molnupiravir is expected to be launched in the Chinese market on Friday, Sinopharm's president Liu Yong was quoted as saying by state-backed media outlet Kankan News on Wednesday.

Merck said earlier in a filing that Sinopharm is the only legally authorized distributor of molnupiravir in China, which is sold under the brand name Lagevrio and was developed by Merck and partner Ridgeback Biotherapeutics.

© 2026 Thomson/Reuters. All rights reserved.


Click Here to comment on this article
Share
StreetTalk
Merck & Co.'s COVID-19 antiviral treatment molnupiravir is expected to be launched in the Chinese market on Friday, Sinopharm's president Liu Yong was quoted as saying by state-backed media outlet Kankan News on Wednesday.
merck covid treatment molnupiravir, china
69
2023-44-11
Wednesday, 11 January 2023 07:44 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the Newsmax App
Apple
Android
Amazon
Samsung
Vizio
Roku
Sony
LG
Scan QR code to get the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved